GRANGE DAVID L

CIK 00012649082 companiesWILMINGTON, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001264908

Recent Transactions

32 trades

Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2025-05-13+10,000→ 10,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2024-05-23+104,621→ 104,621 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2023-05-08+60,000→ 60,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2022-05-09+2,131,500→ 2,131,500 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2021-05-10+270,882→ 270,882 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2020-05-04+75,000→ 75,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2019-05-06+30,000→ 30,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2018-06-12+20,000→ 20,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2018-02-13+7,000→ 7,000 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2011-02-28−34,501→ 69,005 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-02-28$26.00/sh−34,501→ 61,045 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2011-02-28$20.45/sh+34,501→ 95,546 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2010-11-03$21.98/sh+51,380→ 112,425 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2010-11-03−51,380→ 155,259 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2010-11-03$25.71/sh−51,380→ 61,045 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2010-11-02$26.00/sh−373→ 61,045 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2010-11-02−373→ 206,639 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2010-11-02$21.98/sh+373→ 61,418 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2010-06-17+50,000→ 50,000 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2010-02-25+100,000→ 100,000 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2009-07-01+50,000→ 61,045 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2009-07-01+200,000→ 200,000 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2009-01-02+2,242→ 11,045 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2008-01-02+1,588→ 8,803 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2006-01-03+1,032→ 2,612 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2005-07-26$57.44/sh−1,200→ 3,380 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2005-07-26−3,000→ 15,729 total
Exercise/Conversion
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2005-07-26$25.76/sh+3,000→ 4,580 total
Sale
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2005-07-26$57.45/sh−1,800→ 1,580 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Options (to buy)
2005-05-18+2,729→ 18,729 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Common Stock
2005-01-03+1,580→ 1,580 total
Award
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Stock Option (to Buy)
2003-10-15+8,000→ 8,000 total

Companies

Recent Filings

Address

929 NORTH FRONT STREET

WILMINGTON, NC, 28401

View on SEC.gov